Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86591 | Target Info | |||
Target Name | Peroxisome proliferator-activated receptor alpha (PPARA) | ||||
Synonyms | Peroxisome proliferater-activated receptor alpha; PPARalpha; PPAR-alpha; PPAR; Nuclear receptor subfamily 1 group C member 1; NR1C1 | ||||
Target Type | Successful Target | ||||
Gene Name | PPARA | ||||
Biochemical Class | Nuclear hormone receptor | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Ciprofibrate, (S)- | Ligand Info | |||
Canonical SMILES | CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl | ||||
InChI | 1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17)/t10-/m0/s1 | ||||
InChIKey | KPSRODZRAIWAKH-JTQLQIEISA-N | ||||
PubChem Compound ID | 6603766 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6LX5 X-ray structure of human PPARalpha ligand binding domain-ciprofibrate co-crystals obtained by delipidation and co-crystallization | ||||||
Method | X-ray diffraction | Resolution | 1.87 Å | Mutation | No | [1] |
PDB Sequence |
GSHMTADLKS
205 LAKRIYEAYL215 KNFNMNKVKA225 RVILSGKASN235 NPPFVIHDME245 TLCMAEKTLV 255 AKLVANGIQN265 KEAEVRIFHC275 CQCTSVETVT285 ELTEFAKAIP295 GFANLDLNDQ 305 VTLLKYGVYE315 AIFAMLSSVM325 NKDGMLVAYG335 NGFITREFLK345 SLRKPFCDIM 355 EPKFDFAMKF365 NALELDDSDI375 SLFVAAIICC385 GDRPGLLNVG395 HIEKMQEGIV 405 HVLRLHLQSN415 HPDDIFLFPK425 LLQKMADLRQ435 LVTEHAQLVQ445 IIKKTESDAA 455 LHPLLQEIYR465 DMY
|
|||||
|
ILE241
3.104
LEU247
4.227
ALA250
4.345
GLU251
4.936
LEU254
2.701
LYS257
2.475
ARG271
4.737
ILE272
3.491
PHE273
2.923
CYS275
3.532
CYS276
3.003
GLN277
2.570
THR279
2.824
SER280
2.666
GLU282
3.599
TYR314
2.510
PHE318
3.433
|
|||||
PDB ID: 6L37 X-ray structure of human PPARalpha ligand binding domain-GW9662-ciprofibrate co-crystals obtained by delipidation and co-crystallization | ||||||
Method | X-ray diffraction | Resolution | 2.91 Å | Mutation | No | [1] |
PDB Sequence |
MTADLKSLAK
208 RIYEAYLKNF218 NMNKVKARVI228 LSGKASNNPP238 FVIHDMETLC248 MAEKTLVAKL 258 VANGIQNKEA268 EVRIFHCCQC278 TSVETVTELT288 EFAKAIPGFA298 NLDLNDQVTL 308 LKYGVYEAIF318 AMLSSVMNKD328 GMLVAYGNGF338 ITREFLKSLR348 KPFCDIMEPK 358 FDFAMKFNAL368 ELDDSDISLF378 VAAIICCGDR388 PGLLNVGHIE398 KMQEGIVHVL 408 RLHLQSNHPD418 DIFLFPKLLQ428 KMADLRQLVT438 EHAQLVQIIK448 KTESDAALHP 458 LLQEIYRDMY468
|
|||||
|
PHE273
2.799
HIS274
3.985
CYS276
3.146
GLN277
2.531
CYS278
4.947
SER280
2.490
TYR314
2.657
ILE317
4.145
PHE318
3.389
PHE351
4.144
ILE354
3.707
MET355
4.018
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | PPARAlpha Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates. iScience. 2020 Oct 23;23(11):101727. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.